Urologe 1130, Urologie 1130,Urologe Hietzing, Urologie Hietzing

Literatur

Studien-Literatur kann oftmals sehr „trocken“ sein doch ist sie für die medizinische Weiterentwicklung dringend notwendig. Im Anschluss finden Sie eine komplette Liste jener Studien, welche ich in wissenschaftlichen Journalen publiziert habe. Wenn Sie den Link verfolgen, gelangen Sie direkt zur Publikation.

Postprandial blood glucose level in maintenance hemodialysis patients predicts post-transplant-diabetes-mellitus. Haider DG, Mittermayer F, Friedl A, Batrice A, Auinger M, Wolzt M, Hörl WH. Exp Clin Endocrinol Diabetes. 2010 Mar;118(3):200-4. https://www.ncbi.nlm.nih.gov/pubmed/20072964

Glucose metabolism and blood pressure remain unchanged by addition of angiotensin receptor blocker in patients undergoing hemodialysis. Friedl A, Mittermayer F, Wolzt M, Hörl WH, Haider DG; Dialysis and Transplantation, 2011 May;5-40;188-232. https://onlinelibrary.wiley.com/doi/full/10.1002/dat.20553

Kidney biopsy in patients with diabetes mellitus. Haider DG, Peric S, Friedl A, Fuhrmann V, Wolzt M, Hörl WH, Soleiman A. Clin Nephrol. 2011 Sep;76(3):180-5. https://www.ncbi.nlm.nih.gov/pubmed/21888854

Kidney biopsy in patients with glomerulonephritis: is the earlier the better? Haider DG, Friedl A, Peric S, Wiesinger GF, Wolzt M, Prosenz J, Fischer H, Hörl WH, Soleiman A, Fuhrmann V. BMC Nephrol. 2012 Jun 8;13:34. https://www.ncbi.nlm.nih.gov/pubmed/22682295

No association of angiotensin-converting enzyme inhibitor or angiotensin 2 receptor blocker intake with acute kidney injury in patients undergoing kidney biopsy. Friedl A, Peric S, Masghati S, Wolzt M, Hörl WH, Soleiman A, Fuhrmann V, Haider DG. Kidney Blood Press Res. 2012;35(6):558-60.https://www.ncbi.nlm.nih.gov/pubmed/22890200

Urological comorbidities in patients with rheumatoid arthritis : literature review. Friedl A, Mustak M, Höltl W, Erlacher L. Z Rheumatol. 2013 Nov;72(9):910-5. https://www.ncbi.nlm.nih.gov/pubmed/23934052

Urological aspects in patients with liver cirrhosis. Friedl A, Schwarzer R, Schneeweiss J, Brössner C. Urologe A. 2016 Jan;55(1):63-7. https://www.ncbi.nlm.nih.gov/pubmed/26471794

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease. Haider DG, Sauter T, Lindner G, Masghati S, Peric S, Friedl A, Wolzt M, Hörl WH, Soleiman A, Exadaktylos A, Fuhrmann V. Kidney Blood Press Res. 2015;40(6):630-7. https://www.ncbi.nlm.nih.gov/pubmed/26672999

Sexuality and erectile function after implantation of an Adjustable Transobturator Male System (ATOMS) for urinary stress incontinence. A multi-institutional prospective study. Friedl A, Bauer W, Rom M, Kivaranovic D, Lüftenegger W, Brössner C. Arch Ital Urol Androl. 2016 Jan 14;87(4):306-11.https://www.ncbi.nlm.nih.gov/pubmed/26766803

Risk Factors for Treatment Failure With the Adjustable Transobturator Male System Incontinence Device: Who Will Succeed, Who Will Fail? Results of a Multicenter Study. Friedl A, Mühlstädt S, Rom M, Kivaranovic D, Mohammed N, Fornara P, Brössner C. Urology. 2016 Apr;90:189-94. https://www.ncbi.nlm.nih.gov/pubmed/26773347

Xanthogranulomatous Pyelonephritis with Staghorn Calculus, Acute Gangrenous Appendicitis and Enterocolitis: A Multidisciplinary Challenge of Kidney-Preserving Conservative Therapy. Friedl A, Tuerk C, Schima W, Broessner C. Curr Urol. 2015 Sep;8(3):162-5. https://www.ncbi.nlm.nih.gov/pubmed/26889137

Efficacy and safety of the ZSI375 artificial urinary sphincter for male stress urinary incontinence: lessons learned. Kretschmer A, Hüsch T, Thomsen F, Kronlachner D, Pottek T, Obaje A, Anding R, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix JN, Hofmann T, Buchner A, Haferkamp A, Bauer RM. World J Urol. 2016 Oct;34(10):1457-63. https://www.ncbi.nlm.nih.gov/pubmed/26914816

Five-year experience with the adjustable transobturator male system for the treatment of male stress urinary incontinence: a single-center evaluation. Mühlstädt S, Friedl A, Mohammed N, Schumann A, Weigand K, Kawan F, Göllert C, Kahlert C, Theil G, Fischer K, Fornara P. World J Urol. 2017 Jan;35(1):145-151. https://www.ncbi.nlm.nih.gov/pubmed/27156092

Complications and Short-Term Explantation Rate Following Artificial Urinary Sphincter Implantation: Results from a Large Middle European Multi-Institutional Case Series. Kretschmer A, Hüsch T, Thomsen F, Kronlachner D, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix JN, Hofmann T, Seiler R, Haferkamp A, Bauer RM. Urol Int. 2016;97(2):205-11. https://www.ncbi.nlm.nih.gov/pubmed/27310718

Risk Factors for Failure of Male Slings and Artificial Urinary Sphincters: Results from a Large Middle European Cohort Study. Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Bauer RM, Haferkamp A. Urol Int. 2017;99(1):14-21. https://www.ncbi.nlm.nih.gov/pubmed/27598774

Long-term outcome of the adjustable transobturator male system (ATOMS): results of a European multicentre study. Friedl A, Mühlstädt S, Zachoval R, Giammò A, Kivaranovic D, Rom M, Fornara P, Brössner C. BJU Int. 2017 May;119(5):785-792. https://www.ncbi.nlm.nih.gov/pubmed/27868328

Antibiotic Coating of the Artificial Urinary Sphincter (AMS 800): Is it Worthwhile? Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Bauer RM, Haferkamp A. Urology. 2017 May;103:179-184. https://www.ncbi.nlm.nih.gov/pubmed/28093308

Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Perioperative Complications and Device Explantations. Kretschmer A, Hüsch T, Thomsen F, Kronlachner D, Obaje A, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Queissert F, Naumann CM, Wotzka C, Hofmann T, Seiler R, Haferkamp A, Bauer RM. Int Neurourol J. 2017 Jun;21(2):109-115.https://www.ncbi.nlm.nih.gov/pubmed/28673058

The Adjustable Transobturator Male System in Stress Urinary Incontinence After Transurethral Resection of the Prostate. Friedl A, Schneeweiss J, Stangl K, Mühlstädt S, Zachoval R, Hruby S, Gründler T, Kivaranovic D, Fornara P, Lusuardi L, Brössner C. Urology. 2017 Nov;109:184-189. https://www.ncbi.nlm.nih.gov/pubmed/28712889

Prostate-specific Antigen Parameters and Prostate Health Index Enhance Prostate Cancer Prediction With the In-bore 3-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy After Negative 12-Core Biopsy. Friedl A, Stangl K, Bauer W, Kivaranovic D, Schneeweiss J, Susani M, Hruby S, Lusuardi L, Lomoschitz F, Eisenhuber-Stadler E, Schima W, Brössner C. Urology. 2017 Dec;110:148-153. https://www.ncbi.nlm.nih.gov/pubmed/28844600

The TiLOOP® Male Sling: Did We Forejudge? Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Kirschner-Hermanns R, Pottek T, Rose A, Olianas R, Friedl A, Hübner W, Homberg R, Pfitzenmaier J, Grein U, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Brehmer B, Ulm K, Bauer RM, Haferkamp A. Urol Int. 2018;100(2):216-221. https://www.ncbi.nlm.nih.gov/pubmed/29069660

In-bore 3.0-T Magnetic Resonance Imaging-guided Transrectal Targeted Prostate Biopsy in a Repeat Biopsy Population: Diagnostic Performance, Complications, and Learning Curve. Friedl A, Schneeweiss J, Sevcenco S, Eredics K, Kunit T, Susani M, Kivaranovic D, Eisenhuber-Stadler E, Lusuardi L, Brössner C, Schima W. Urology. 2018 Apr;114:139-146. https://www.ncbi.nlm.nih.gov/pubmed/29330001

The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference? Hüsch T, Kretschmer A, Thomsen F, Kronlachner D, Kurosch M, Obaje A, Anding R, Kirschner-Hermanns R, Pottek T, Rose A, Olianas R, Lusuardi L, Friedl A, Homberg R, Pfitzenmaier J, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Brehmer B, Abdunnur R, Loertzer H, Ulm K, Hübner W, Bauer RM, Haferkamp A. World J Urol. 2018 Oct;36(10):1657-1662. https://www.ncbi.nlm.nih.gov/pubmed/29728764

Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer. Sevcenco S, Klingler HC, Eredics K, Friedl A, Schneeweiss J, Knoll P, Kunit T, Lusuardi L, Mirzaei S. Adv Ther. 2018 Jun;35(6):779-784. https://www.ncbi.nlm.nih.gov/pubmed/29777523

Bladder cancer in nonagenarians:a multicenter study of 123 patients. Eredics K, Bretterbauer KM, Comploj E, Friedl A, Gschliesser T, Lenart S, Seklehner S, Wimpissinger F, Madersbacher S. BJU Int. 2018 Dec;122(6):1010-1015. https://www.ncbi.nlm.nih.gov/pubmed/29804311

Comparison of adjustable male slings and artificial urinary sphincter in the treatment of male urinary incontinence: a retrospective analysis of patient selection and postoperative continence status. Grabbert M, Hüsch T, Kretschmer A, Kirschner-Hermanns R, Anding R, Rose A, Friedl A, Obaje A, Heidenreich A, Brehmer B, Naumann CM, Queissert F, Loertzer H, Pfitzenmaier J, Nyarangi-Dix J, Kurosch M, Olianas R, Homberg R, Abdunnur R, Schweiger J, Hofmann T, Wotzka C, Pottek T, Huebner W, Haferkamp A, Bauer RM. World J Urol. 2018 Oct 19. doi: 10.1007/s00345-018-2523-0. https://www.ncbi.nlm.nih.gov/pubmed/30341450

An overview of the ATOMS generations: port types, functionality and risk factors. Mühlstädt S, Friedl A, Zachoval R, Mohammed N, Schumann A, Theil G, Fornara P. World J Urol. 2018 Oct 30. doi: 10.1007/s00345-018-2548-4. https://www.ncbi.nlm.nih.gov/pubmed/30377812

Artificial Urinary Sphincter Cuff Size Predicts Outcome in Male Patients Treated for Stress Incontinence: Results of a Large Central European Multicenter Cohort Study. Queissert F, Huesch T, Kretschmer A, Anding R, Kurosch M, Kirschner-Hermanns R, Pottek T, Olianas R, Friedl A, Pfitzenmaier J, Naumann CM, Wotzka C, Nyarangi-Dix J, Hoffmann T, Herrmann E, Obaje A, Rose A, Homberg R, Abdunnur R, Loertzer H, Bauer RM, Haferkamp A, Schrader AJ. Int Neurourol J. 2019 Sep;23(3):219-225.

High/low-volume center experience predicts outcome of AMS 800 in male stress incontinence: Results of a large middle European multicenter case series.Queissert F, Hüsch T, Kretschmer A, Anding R, Kirschner-Hermanns R, Pottek T, Olianas R, Friedl A, Homberg R, Pfitzenmaier J, Naumann CM, Nyarangi-Dix J, Hofmann T, Rose A, Schweiger J, Hübner W, Loertzer H, Bauer RM, Haferkamp A, Schrader AJ. Neurourol Urodyn. 2020 Jun 22. doi: 10.1002/nau.24444. https://pubmed.ncbi.nlm.nih.gov/32567709/

Fixed or adjustable sling in the treatment of male stress urinary incontinence: results from a large cohort study. Hüsch T, Kretschmer A, Obaje A, Kirschner-Hermanns R, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Homberg R, Pfitzenmaier J, Abdunnur R, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Hübner W, Bauer RM, Haferkamp A; https://pubmed.ncbi.nlm.nih.gov/32676393/

  • „Doktor Friedl ist ein absoluter Fachmann in seinem Gebiet. Schöne Ordination, kaum Wartezeiten, sehr fürsorgliche Betreuung vor, während und nach der Operation. Dafür danke ich Ihm sehr.“

    Gustav E.

  • „Ich bin sehr froh Dozent Friedl kennengelernt zu haben. Nach der Behandlung ging es mir wieder sehr gut und ich habe keinen Harnverlust mehr. Ich kann diesen Arzt nur weiterempfehlen.“

    Angelika H.

  • „Vor wenigen Wochen hatte ich akute Probleme beim Wasserlassen. Dr. Friedl ist sehr sympathisch und ging auf meine Beschwerden sofort ein. Nach einer Untersuchung erklärte er mir die Ursachen und verordnete eine Therapie. Jetzt bin ich wieder gesund. Vielen Dank! Ich werde ab sofort regelmäßig zur Vorsorge gehen!“

    Robert S.

Haben Sie Fragen an Priv.-Doz. Dr. Alexander Friedl?

Wir freuen uns über Ihre Kontaktaufnahme und werden uns so rasch wie möglich bei Ihnen melden!

Danke!

Wir haben Ihre Nachricht erhalten und werden uns so rasch wie möglich bei Ihnen melden.

×
Top